Human umbilical cord blood endothelial progenitor cells decrease vein graft neointimal hyperplasia in SCID mice

Atherosclerosis

Volumn 212, Issue 1, 2010, Pages 63-69

  Zhu, Shoukang ^a   Malhotra, Anuj ^b   Zhang, Lisheng ^b   Deng, Shanming ^a   Zhang, Taifang ^a   Freedman, Neil J ^b   Storms, Robert ^b   Peppel, Karsten ^b   Goldschmidt Clermont, Pascal J ^a   Dong, Chunming ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Endothelial progenitor cells; Umbilical cord blood; Vascular repair

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFERIOR CAVA VEIN; INFLAMMATION; INTRAOPERATIVE PERIOD; ISOGRAFT; MOUSE; NONHUMAN; PARACRINE SIGNALING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCID MOUSE; STEM CELL; UMBILICAL CORD BLOOD; VEIN GRAFT;

ANIMALS; CAROTID ARTERIES; CELL DIFFERENTIATION; CELL PROLIFERATION; CORD BLOOD STEM CELL TRANSPLANTATION; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; HYPERPLASIA; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, SCID; PARACRINE COMMUNICATION; REGENERATION; TIME FACTORS; TUNICA INTIMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENA CAVA, INFERIOR;

EID: 77956229941     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.04.018     Document Type: Article

References (28)

1. Zwolak R.M., Adams M.C., Clowes A.W. Kinetics of vein graft hyperplasia: association with tangential stress. J Vasc Surg 1987, 5(1):126-136.
2. Eslami M.H., Gangadharan S.P., Belkin M., et al. Monocyte adhesion to human vein grafts: a marker for occult intraoperative injury?. J Vasc Surg 2001, 34(5):923-929.
3. Mann M.J., Dzau V.J. Genetic manipulation of vein grafts. Curr Opin Cardiol 1997, 12(6):522-527.
4. Zhang L., Peppel K., Brian L., Chien L., Freedman N.J. Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells. Arterioscler Thromb Vasc Biol 2004, 24(12):2277-2283.
5. Dong C., Crawford L.E., Goldschmidt-Clermont P.J. Endothelial progenitor obsolescence and atherosclerotic inflammation. J Am Coll Cardiol 2005, 45(9):1458-1460.
6. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275(5302):964-967.
7. Lin Y., Weisdorf D.J., Solovey A., Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000, 105(1):71-77.
8. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89(1):E1-E7.
9. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348(7):593-600.
10. Murohara T., Ikeda H., Duan J., et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000, 105(11):1527-1536.
11. Vaziri H., Dragowska W., Allsopp R.C., et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994, 91(21):9857-9860.
12. Goodwin H.S., Bicknese A.R., Chien S.N., et al. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 2001, 7(11):581-588.
13. Zhu S., Liu X., Li Y., Goldschmidt-Clermont P.J., Dong C. Aging in the atherosclerosis milieu may accelerate the consumption of bone marrow endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2007, 27(1):113-119.
14. Rauscher F.M., Goldschmidt-Clermont P.J., Davis B.H., et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003, 108(4):457-463.
15. Zhang L., Hagen P.O., Kisslo J., Peppel K., Freedman N.J. Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model. J Vasc Surg 2002, 36(4):824-832.
16. Xu Q., Zhang Z., Davison F., Hu Y. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res 2003, 93(8):e76-e86.
17. Mayr U., Zou Y., Zhang Z., et al. Accelerated arteriosclerosis of vein grafts in inducible NO synthase(-/-) mice is related to decreased endothelial progenitor cell repair. Circ Res 2006, 98(3):412-420.
18. Sainz J., Sata M. Maintenance of vascular homeostasis by bone marrow-derived cells. Arterioscler Thromb Vasc Biol 2006, 26(6):1196-1197.
19. Murugesan S., Mousa S.A., O'connor L.J., Lincoln D.W., Linhardt R.J. Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis. FEBS Lett 2007, 581(6):1157-1160.
20. Zhang L., Freedman N.J., Brian L., Peppel K. Graft-extrinsic cells predominate in vein graft arterialization. Arterioscler Thromb Vasc Biol 2004, 24(3):470-476.
21. He T., Smith L.A., Harrington S., et al. Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 2004, 35(10):2378-2384.
22. Kong D., Melo L.G., Gnecchi M., et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004, 110(14):2039-2046.
23. Jiang Y., Jahagirdar B.N., Reinhardt R.L., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418(6893):41-49.
24. Hinokiyama K., Valen G., Tokuno S., Vedin J.B., Vaage J. Vein graft harvesting induces inflammation and impairs vessel reactivity. Ann Thorac Surg 2006, 82(4):1458-1464.
25. Leonard E.J., Skeel A., Yoshimura T. Biological aspects of monocyte chemoattractant protein-1 (MCP-1). Adv Exp Med Biol 1991, 305:57-64.
26. Tatewaki H., Egashira K., Kimura S., et al. Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation. J Vasc Surg 2007, 45(6):1236-1243.
27. Selzman C.H., Miller S.A., Zimmerman M.A., et al. Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. Am J Physiol Heart Circ Physiol 2002, 283(4):H1455-H1461.
28. Schepers A., Eefting D., Bonta P.I., et al. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo. Arterioscler Thromb Vasc Biol 2006, (9):2063-2069.